CollPlant Biotechnologies Analyst Ratings
CollPlant Biotechnologies Analyst Ratings
While ratings are subjective and will change, the latest CollPlant Biotechnologies (CLGN) rating was a initiated with a price target of $0.00 to $22.75. The current price CollPlant Biotechnologies (CLGN) is trading at is $11.80, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/17/2023 | 92.8% | Alliance Global Partners | → $22.75 | Initiates Coverage On | → Buy |
| 02/09/2021 | 120.34% | HC Wainwright & Co. | $13 → $26 | Maintains | Buy |
| 05/28/2020 | 10.17% | HC Wainwright & Co. | $11 → $13 | Reiterates | → Buy |
| 04/03/2020 | -6.78% | HC Wainwright & Co. | $7 → $11 | Reiterates | → Buy |
| 12/18/2018 | -40.68% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变化 | 上一页/当前额定值 |
|---|---|---|---|---|---|
| 02/17/2023 | 92.8% | 联盟全球合作伙伴 | → 22.75 美元 | 开启覆盖范围 | → 购买 |
| 02/09/2021 | 120.34% | HC Wainwright & Co. | 13 美元 → 26 美元 | 维护 | 买 |
| 05/28/2020 | 10.17% | HC Wainwright & Co. | 11 美元 → 13 美元 | 重申 | → 购买 |
| 04/03/2020 | -6.78% | HC Wainwright & Co. | 7 美元 → 11 美元 | 重申 | → 购买 |
| 2018 年 12 月 18 日 | -40.68% | HC Wainwright & Co. | → 7 美元 | 开启覆盖范围 | → 购买 |
What is the target price for CollPlant Biotechnologies (CLGN)?
CollPlant Biotechnologies（CLGN）的目标价格是多少？
The latest price target for CollPlant Biotechnologies (NASDAQ: CLGN) was reported by Alliance Global Partners on February 17, 2023. The analyst firm set a price target for $22.75 expecting CLGN to rise to within 12 months (a possible 92.80% upside). 1 analyst firms have reported ratings in the last year.
联盟全球合作伙伴于2023年2月17日公布了CollPlant Biotechnologies（纳斯达克股票代码：CLGN）的最新目标股价。这家分析公司将目标价设定为22.75美元，预计CLGN将在12个月内升至12个月（可能上涨92.80％）。1家分析公司去年公布了评级。
What is the most recent analyst rating for CollPlant Biotechnologies (CLGN)?
CollPlant Biotechnologies（CLGN）的最新分析师评级是多少？
The latest analyst rating for CollPlant Biotechnologies (NASDAQ: CLGN) was provided by Alliance Global Partners, and CollPlant Biotechnologies initiated their buy rating.
CollPlant Biotechnologies（纳斯达克股票代码：CLGN）的最新分析师评级由Alliance Global Partners提供，CollPlant
When is the next analyst rating going to be posted or updated for CollPlant Biotechnologies (CLGN)?
CollPlant Biotechnologies（CLGN）的下一个分析师评级将在何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CollPlant Biotechnologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CollPlant Biotechnologies was filed on February 17, 2023 so you should expect the next rating to be made available sometime around February 17, 2024.
分析师在进行了广泛的研究后得出了股票评级，包括浏览公开财务报表，与CollPlant Biotechnologies的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月这样做一次，因此每家公司每年应该获得4次评级。CollPlant Biotechnologies的最新评级是在2023年2月17日公布的，因此你应该预计下一个评级将在2024年2月17日左右公布。
Is the Analyst Rating CollPlant Biotechnologies (CLGN) correct?
分析师对CollPlant Biotechnologies（CLGN）的评
While ratings are subjective and will change, the latest CollPlant Biotechnologies (CLGN) rating was a initiated with a price target of $0.00 to $22.75. The current price CollPlant Biotechnologies (CLGN) is trading at is $11.80, which is within the analyst's predicted range.
虽然评级是主观的，而且会发生变化，但最新的CollPlant Biotechnologies（CLGN）评级最初是最初的，目标价为0.00美元至22.75美元。CollPlant Biotechnologies（CLGN）目前的交易价格为11.80美元，在分析师的预测区间内。